::: Pharmacovigilance : Pharmaco Vigilance Unit
PHARMACOVIGILANCE PROGRAMME OF INDIA(PvPI)
Introduction:
          Ministry of health and family welfare, Government of India, launched a national wide Pharmacovigilance programme of India (PvPI) to monitor the safety of medicines in indian population. Indian Pharmacopoeia Commission (IPC) is functioning as National Coordination centre   (NCC) to collate ADR reports and recommend Central Drug Standard Control Organization (CDSCO) for regulatory intervention.   
  
                    Coimbatore Medical College and Hospital(CMCH) Pharmacovigilance centre joined the PvPI programme since 2010.Has been recognized by PvPI and designated as Adverse Drug Monitoring centre.CMCH-AMC started sending ADR reports directly to NCC-PvPI through Vigiflow software. The centre works under Dr.Edwin joe M.D (Dean Coimbatore Medical College and  Hospital)Coordinator Dr.N.Santhi M.D (Prof &HOD Dept of Pharmacology CMC, Coimbatore)Depty Coordinator Dr.R.Mani M.D (Prof &VP Dept of Pharmacology CMC, Coimbatore)Technical Associate S.Muthukumar(M.pharm). CMCH has total number of 42 departments and the doctors of 280 and 242 PG students .Our hospital has a facility of 1982 beds in that daily In Patient (IP) of 1500 patients and Out Patient (OP) of 7000 patients.

 
Pharmacovigilance:
 
        The science and activities relating to the detection, assessment understanding and prevention of adverse effects or any other drug related problem. This PvPI  programme works associated with CDSCO(Central Drug Standard Control Organization),AMCs(ADR Monitoring Centre),WHO-UMC(Sweden),National health prorammes and other Government and Non Government Organizations.

 
Objective:
  1. To create a nationwide system for patient safety reporting
  2. To identify and analyze new signal from the reported cases
  3. To support regulatory agencies in the decision making process on use of medication.
  4. To emerge as a national centre of excellence for Pharmacovigilance
ADR (Adverse Drug Reaction)
          A response to a drug which is noxious and unintended and which occurs at doses normally used in human for the prophylaxis diagnosis or treatment of disease

Sources of ADR Collection
  1. Health care providers(Doctors, Nurse& pharmacist )
  2. Pharmaceutical  Industries
  3. National Health programme’s
  4. Patients
Channels of ADR Reporting
  1. Suspected  Adverse Drug Reaction (ADR) Reporting Form.
  2. Medicines side Effect Reporting Form (For Consumers)
  3. Toll Free Number  1800-180-3024
  4. Mobile application(ADR Reporting)
  5. E-Reporting
 
Action on Adverse Drug Reaction (ADR) Forms:
Downloading the following  information


Suspected Adverse Drug reaction reputing forms (Healthcare Professionals & Non – Healthcare Professionals)
Medicine Side effect reporting for (Consumers)


News Letter:

The following informations  to be download through the following link
www.ipc.gov.in  (PVPI UPDATES)

 
Communication Information:-

S.Muthukumar

(Technical Associate)
9788628886

 

Designed & Developed by

This site can be best viewed in 1024x768 screen resolution.